根据重症急性呼吸综合征冠状病毒2(冠状病毒病2019)感染所接受呼吸支持水平分层的住院死亡率:一项前瞻性多中心研究
该研究分析了Coracle注册研究中2020年2月22日至4月1日意大利皮埃蒙特、伦巴第、托斯卡纳和拉齐奥大区948例COVID-19住院患者,按所接受的最大呼吸支持程度分组,报告住院死亡率。接受有创通气者122例(12.87%),仅补氧者637例(67.19%),未接受呼吸支持者189例(19.94%)。住院死亡率分别为有创通气22.95%、仅补氧12.87%、未接受呼吸支持7.41%(p=0.0004)。在小于80岁的770例患者中进行敏感性分析,死亡率趋势相似但更低(分别为18.02%、8.10%、5.23%;p=0.0008)。
要点
- 948例COVID-19住院患者中,接受有创通气者122例(12.87%),其住院死亡率为22.95%。
- 仅接受补氧者637例(67.19%),住院死亡率为12.87%;未接受呼吸支持者189例(19.94%),住院死亡率为7.41%(p=0.0004)。
- 小于80岁的770例患者敏感性分析显示相似趋势:有创通气、仅补氧、未接受呼吸支持者死亡率分别为18.02%、8.10%、5.23%(p=0.0008)。
- 呼吸治疗按年龄 decade 存在差异(p=0.0046),80岁以上患者通常未接受插管。
- 男性606例(63.9%),较女性更可能接受呼吸支持(p<0.0001)。
适用人群与场景
- 2020年2月22日至2020年4月1日期间在意大利皮埃蒙特、伦巴第、托斯卡纳和拉齐奥大区医院住院的COVID-19患者,共948例。
研究设计与关键结果
- 研究类型为前瞻性多中心注册研究分析,纳入948例COVID-19住院患者,无干预。
- 按最大呼吸支持程度分组:有创通气122例(12.87%),仅补氧637例(67.19%),未接受呼吸支持189例(19.94%)。
- 住院死亡率:有创通气组22.95%,仅补氧组12.87%,未接受呼吸支持组7.41%(p=0.0004)。
- 小于80岁的770例患者敏感性分析:有创通气组(占14.42%)死亡率18.02%,仅补氧组(占65.71%)死亡率8.10%,未接受呼吸支持组(占19.87%)死亡率5.23%(p=0.0008)。
- 接受有创通气者中,死亡者中位年龄68.5岁(60-81.36)显著高于存活者62.5岁(55.52-71)(p=0.0145)。
- 呼吸治疗按年龄 decade 存在差异(p=0.0046),80岁以上患者通常未接受插管;男性606例(63.9%),较女性更可能接受呼吸支持(p<0.0001)。
证据类型、等级与局限
- 证据类型:前瞻性多中心注册研究分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To describe patients according to the maximum degree of respiratory support received and report their inpatient mortality due to coronavirus disease 2019.
DESIGN: Analysis of patients in the Coracle registry from February 22, 2020, to April 1, 2020.
SETTING: Hospitals in the Piedmont, Lombardy, Tuscany, and Lazio regions of Italy.
PATIENTS: Nine-hundred forty-eight patients hospitalized for coronavirus disease 2019.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Among 948 patients, 122 (12.87%) received invasive ventilation, 637 (67.19%) received supplemental oxygen only, and 189 (19.94%) received no respiratory support. The median (quartile 1-quartile 3) age was 65 years (54-76.59 yr), and there was evidence of differential respiratory treatment by decade of life (p = 0.0046); patients greater than 80 years old were generally not intubated. There were 606 men (63.9%) in this study, and they were more likely to receive respiratory support than women (p < 0.0001). The rate of in-hospital death for invasive ventilation recipients was 22.95%, 12.87% for supplemental oxygen recipients, and 7.41% for those who received neither (p = 0.0004). A sensitivity analysis of the 770 patients less than 80 years old revealed a lower, but similar mortality trend (18.02%, 8.10%, 5.23%; p = 0.0008) among the 14.42%, 65.71%, and 19.87% of patients treated with mechanical ventilation, supplemental oxygen only, or neither. Overall, invasive ventilation recipients who died were significantly older than those who survived (median age: 68.5 yr [60-81.36 yr] vs 62.5 yr [55.52-71 yr]; p = 0.0145).
CONCLUSIONS: Among patients hospitalized for coronavirus disease 2019, 13% received mechanical ventilation, which was associated with a mortality rate of 23%.
参考来源
- Palazzuoli A, Ruberto F, De Ferrari GM, et al. Inpatient Mortality According to Level of Respiratory Support Received for Severe Acute Respiratory Syndrome Coronavirus 2 (Coronavirus Disease 2019) Infection: A Prospective Multicenter Study. Crit Care Explor. 2020. PMID: 32984838. doi:10.1097/CCE.0000000000000220
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。